Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TTAX03 in Mild to Moderate Dry Eye Disease
NCT06780306Phase 2Completed
- Sponsor
- BioTissue
- Start
- Dec 2024
- Primary completion
- Jan 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of TTAX03 in dry eye disease (DED), sponsored by BioTissue. Started Dec 2024; status: completed.
02
Drugs
TTAX03
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06780306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06780306.